Tech Company Financing Transactions

Navitor Pharmaceuticals Funding Round

Navitor Pharmaceuticals closed a $33 million Series B funding round on 12/18/2015. Investors included Brace Pharma, Atlas Venture and Johnson & Johnson Development Corporation.

Transaction Overview

Company Name
Navitor Pharmaceuticals
Announced On
12/18/2015
Transaction Type
Venture Equity
Amount
$33,000,000
Round
Series B
Investors

Brace Pharma (Lead Investor) (Vinzenz Ploerer)

Atlas Venture (Jean-François Formela)

Johnson & Johnson Development Corporation (Marian Nakada)

Polaris Partners (Alan Crane)

Remeditex Ventures (Barry Burgdorf)

Sanofi-Genzyme BioVentures

SR One Capital Management (Brian Gallagher)

Proceeds Purpose
The Series B funding will enable Navitor to advance a lead program into clinical trials with the objective of demonstrating initial efficacy and safety. The company will also continue to develop additional pipeline candidates and augment its proprietary drug discovery platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1030 Massachusetts Ave. 410
Cambridge, MA 02138
USA
Phone
(781) 258-6153
Website
www.navitorpharma.com
Email Address
[email protected]
Overview
New scientific insights are emerging regarding the primal signaling pathways that direct an organism's metabolic response to conditions in its environment--such as dynamic changes in the availability of nutrients, energy, oxygen and other factors--and the role of these metabolic signaling pathways in disease.
Profile
Navitor Pharmaceuticals LinkedIn Company Profile
Social Media
Navitor Pharmaceuticals Company Twitter Account
Company News
Navitor Pharmaceuticals News
Facebook
Navitor Pharmaceuticals on Facebook
YouTube
Navitor Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Thomas Hughes
  Thomas Hughes LinkedIn Profile  Thomas Hughes Twitter Account  Thomas Hughes News  Thomas Hughes on Facebook
Chief Medical Officer
James Owen
  James Owen LinkedIn Profile  James Owen Twitter Account  James Owen News  James Owen on Facebook
VP - Bus. Development
Rick Lundberg
  Rick Lundberg LinkedIn Profile  Rick Lundberg Twitter Account  Rick Lundberg News  Rick Lundberg on Facebook
VP - R & D
Eddine Saiah
  Eddine Saiah LinkedIn Profile  Eddine Saiah Twitter Account  Eddine Saiah News  Eddine Saiah on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/18/2015: Rivigo venture capital transaction
Next: 12/18/2015: Innervate venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.